Company Overview and News

 
Bursa Malaysia ends lower

2018-10-09 malaymail
KUALA LUMPUR, Oct 9 — Bursa Malaysia ended in the red today in line with the weaker performance in most regional markets on lack of positive catalysts, said a dealer.
PBLOF UPBMF BATS 4162 1295 2089 5256 5199 5225 5819 Q0F BSMAF IHHHF HIPEF 1818

 
Rebound in crude oil prices may not lift all players

2018-10-09 theedgemarkets
WHILE crude oil has rebounded to over US$80 per barrel and sentiment on the oil and gas sector has turned bullish, the recovery in prices may not lift all players in the industry.
4456 7251 5183 PECGF 5141 HIPEF 5256 5199

 
KLCI pares loss as region remains weaker

2018-10-09 theedgemarkets
KUALA LUMPUR (Oct 9): The FBM KLCI pared some of its losses at the midday break today, against a backdrop of weaker regional markets.
HLFBF UPBMF 7036 1082 5010 BATS 4162 2291 7765 3794 2089 5256 9334 5199 KLKBY 5139 2445 0900 8613 6888 AXXTF 5827 HIPEF 3719

 
KLCI remains in the red in tandem with regional markets

2018-10-09 theedgemarkets
KUALA LUMPUR (Oct 9): The FBM KLCI remained in negative zone at mid-morning today, in tandem with regional markets that were also mostly in the red.
SPMXF UPBMF 7036 1163 7087 ORHLF 5168 2089 5256 9334 4006 KLKBY 2445 SPMXY 5819 HRGHY

 
Reach Energy active, up 5.88% on drilling first well in Kariman field

2018-10-09 theedgemarkets
KUALA LUMPUR (Oct 9): Reach Energy Bhd rose 5.88% ina ctive trade this morning after the company drilled its first exploration well on its Emir-Oil asset in the Kariman field, Kazakhstan on Oct 6.
5256

 
KL shares open marginally lower on lack of fresh leads

2018-10-09 malaymail
KUALA LUMPUR, Oct 9 — Bursa Malaysia opened marginally lower on lack of fresh leads and in line with the lacklustre performance of regional markets.
PBLOF 5225 7108 5819 7036 1295 Q0F BSMAF IHHHF 5256 GEBHF 1818

 
Reach Energy rises 7% on drilling in Kariman

2018-10-09 thestar.com.my
KUALA LUMPUR: Shares of Reach Energy Bhd rises 5.88% in early trade Tuesday after the company announced it started drilling first exploration well in Kazakhstan-based Kariman field as part of its Emir-Oil’s exploration commitment.
5256

 
Trading ideas: T7 Global, Reach Energy, IHH Healthcare

2018-10-09 thestar.com.my
KUALA LUMPUR: JF Apex Research expects T7 Global Bhd , Reach Energy Bhd and IHH Healthcare Bhd to be among the stocks to watch following their latest news.
5225 Q0F IHHHF 5256

 
KLCI to stay lacklustre, hurdle at 1,790

2018-10-08 theedgemarkets
KUALA LUMPUR (Oct 9): The FBM KLCI is expected to stay lacklustre today with immediate hurdle at 1,790-points, in line with the overnight fall at most global markets.
5148 5225 Q0F IHHHF 5256 0131

 
UEM Sunrise, T7, Reach Energy, MMC Corp, Gamuda, MCE Holdings and IHH Healthcare

2018-10-08 theedgemarkets
KUALA LUMPUR (Oct 8): Based on corporate announcements and news flow today, companies in focus on Tuesday (Oct 9) may include: UEM Sunrise Bhd, T7 Global Bhd, Reach Energy Bhd, MMC Corp Bhd, Gamuda Bhd, MCE Holdings Bhd and IHH Healthcare Bhd.
5148 5225 7245 Q0F IHHHF 5256 0131 5001

 
Reach Energy spuds first exploration well in Kariman field

2018-10-08 theedgemarkets
KUALA LUMPUR (Oct 8): Reach Energy Bhd has drilled its first exploration well on its Emir-Oil asset in the Kariman field, Kazakhstan on Oct 6.
BSMAF 5256 1818

 
Bursa Malaysia ends easier

2018-10-08 malaymail
KUALA LUMPUR, Oct 8 — Bursa Malaysia ended in negative territory today, weighed down by a broad market selldown against a backdrop of weaker regional markets, said a dealer.
PBLOF 5225 Q0F 1295 BSMAF IHHHF HIPEF 5256 1818 5199

 
KLCI remains marginally lower, construction stocks fall

2018-10-08 theedgemarkets
KUALA LUMPUR (Oct 8): The FBM KLCI remained marginally in the negative zone, having pared much of its losses in the morning session today, against the backdrop of weaker regional markets.
SPMXF 7036 5681 5263 BATS 4162 1163 5256 7123 5199 SPMXY 5225 3026 3301 3867 1899 Q0F IHHHF HIPEF GEBHF

1
Bursa slips further on roaring US economy

2018-10-06 thestar.com.my
REVIEW: Surging US bond yields once again emerged as a key catalyst to watch for in the later half of the trading week after days of cautionary trading on Bursa Malaysia.
NMR 5256 5199 1201 8604 N33 NRSCF JEF MS BSMAF HIPEF 1818

 
Contract flows in Malaysian firms remain flat despite higher oil prices

2018-10-04 thestar.com.my
Kenanga Research added that green field-based projects, such as exploration or new-oil production based jobs, could see a lagged surge, given its huge capex nature and drawn-out planning process. The research house said the companies likely to benefit from this would be those with direct exploration and production (E&P) exposure such as Sapura Energy Bhd, Reach Energy Bhd and Hibiscus Petroleum Bhd.
7293 5141 HIPEF 5256 5199

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...